-+ 0.00%
-+ 0.00%
-+ 0.00%

BTIG Maintains Buy on Innoviva, Raises Price Target to $42

Benzinga·05/07/2026 10:17:31
Listen to the news
BTIG analyst Julian Harrison maintains Innoviva (NASDAQ:INVA) with a Buy and raises the price target from $35 to $42.